## Distinguishing NPC from Nasopharyngeal Lymphoma ### Key Epidemiological and Virological Differences **Key Point:** EBV association is the hallmark discriminator between NPC (especially undifferentiated squamous cell carcinoma) and nasopharyngeal lymphoma. | Feature | Nasopharyngeal Carcinoma | Nasopharyngeal Lymphoma | |---------|--------------------------|------------------------| | **EBV Association** | Strong (90–100% in undifferentiated type) | Absent or rare | | **Histology** | Squamous cell carcinoma (keratinizing, non-keratinizing, undifferentiated) | B-cell or T-cell lymphoma | | **Age of Onset** | 40–60 years (endemic areas) | Broader age range; often older | | **Geographic Variation** | High in Southeast Asia, North Africa, southern China | No strong geographic clustering | | **Lymphadenopathy** | Cervical nodes common (metastatic) | Generalized lymph node involvement | | **Prognosis** | Stage-dependent; undifferentiated type has better response to chemoradiation | Depends on lymphoma grade and stage | ### Why EBV is the Best Discriminator 1. **Molecular Marker:** In-situ hybridization for EBV-encoded RNA (EBER) is positive in >90% of undifferentiated NPC but negative in lymphomas. 2. **Pathogenic Role:** EBV drives transformation in NPC through latent infection; lymphomas arise from different oncogenic pathways (t(14;18), MYC translocations, etc.). 3. **Diagnostic Utility:** EBV serology (VCA-IgA, EBNA) and tissue EBER testing are standard diagnostic tools for NPC but not for lymphoma. **High-Yield:** Undifferentiated NPC is virtually synonymous with EBV positivity in endemic regions; this is a board-level discriminator. **Clinical Pearl:** A nasopharyngeal mass with cervical lymphadenopathy + positive EBER + elevated VCA-IgA titers = NPC until proven otherwise. Lymphoma would show no EBV association and would present with generalized lymphadenopathy and systemic B symptoms more prominently. [cite:Harrison 21e Ch 105] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.